Pharmacy Times
MAY 27, 2024
UC Davis Health researchers uncover substantial treatment disparities and inequal access to autologous hematopoietic cell transplantation therapy among multiple myeloma patients.
STAT
MAY 27, 2024
Here are some things A. was told when she arrived at the hospital one night in June 2023. That she couldn’t have the pain medicine she usually got for a sickle cell crisis because she was six weeks pregnant, but she could have Tylenol. That if she just took her blood thinner everything would be fine. That she needed to leave, and if she still felt bad by the time she’d wheelchaired out into the parking lot, she could turn around and check herself back into the emergency room.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
MAY 27, 2024
Australia, Québec, and Sweden have defined processes for reimbursements by health technology assessments, but the United States has a low reliance rate.
STAT
MAY 27, 2024
At the height of the Covid-19 pandemic, 25 heads of government issued an extraordinary call for a new international treaty for preventing, preparing for, and responding to pandemics. For two years, World Health Organization member states have been negotiating an international agreement scheduled for adoption at the World Health Assembly this month. Yet, late Friday in Geneva, negotiations ground to a halt.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
MAY 27, 2024
The overall survival (OS) data has come in from the TROPION-Lung01 study of AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan (Dato-DXd) in lung cancer – and the result likely isn’t what they were hoping for.
STAT
MAY 27, 2024
Japanese drugmaker Nippon Shinyaku said on Monday that its Duchenne muscular dystrophy drug, Viltepso, part of a controversial class of treatments for the rare disease, had failed to reach its primary endpoint in a placebo-controlled confirmatory trial. Children who received the drug could stand up faster from the floor at the end of the study, but so could children who received a placebo.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
MAY 27, 2024
Thousands of cancer researchers and clinicians are flocking to Chicago for the American Society of Clinical Oncology annual meeting that starts Friday. The ASCO meeting is where clinicians expect to see exciting new science or research that might advance patient care, cancer treatments, and health equity. With over 5,000 research abstracts presented or published at this year’s meeting, though, it can be hard to know where to look.
European Pharmaceutical Review
MAY 27, 2024
Repurposing cyclophosphamide may enable more patients with high-risk blood cancers to receive transplanted stem cells from unrelated, partially matched donors, new research suggests. These new findings, which are part of an ongoing Phase II study , will be presented at the 2024 American Society of Clinical Oncology (ASCO) meeting and the European Hematology Association ( Abstract #6503 ).
pharmaphorum
MAY 27, 2024
The future of Nippon Shinyaku’s Duchenne muscular dystrophy (DMD) therapy Viltepso has been thrown into doubt after it failed a confirmatory clinical trial
OctariusRx
MAY 27, 2024
On this Memorial Day we honor those who made the ultimate sacrifice for our country, and we remember that our freedom isn’t free! “We sleep safely at night because rough men stand ready to visit violence on those who would harm us.” — Winston S. Churchill The OctariusRx team wishes you a peaceful and blessed Memorial Day ! From the bottom of our hearts, thank you to all those who served and gave their lives for our freedom, and the families who supported their heroic efforts.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
pharmaphorum
MAY 27, 2024
Sanofi should hear from the FDA in September about its filing for Sarclisa as a first-line therapy for multiple myeloma after a priority review
The Guardian - Pharmaceutical Industry
MAY 27, 2024
Amid baby boom reports linked to drugs such as Wegovy and Ozempic, experts say it would be ‘wise’ to take extra precautions Claims that “skinny jabs” are fuelling an unexpected baby boom have led experts to warn women to pair their use with effective contraception. Medications such as Wegovy and Ozempic, both of which contain semaglutide, have become hugely popular, not least because they can help people lose more than 10% of their body weight.
pharmaphorum
MAY 27, 2024
Eli Lilly is determined not to be left behind when it comes to manufacturing capacity for new diabetes and obesity therapies, raising its spending on a new plant in Indiana, US, to $9 billion.
The FDA Law Blog
MAY 27, 2024
Hyman, Phelps & McNamara, P.C. (HPM) proudly announces the return of Jennifer Newberger as a Director, further boosting its already robust medical device practice. Jennifer’s combination of experiences as in-house counsel for both large and start-up companies as well as outside counsel provides clients invaluable expertise and problem-solving skills.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmaceutical Commerce
MAY 27, 2024
The latest news for pharma industry insiders.
Pharma Tutor
MAY 27, 2024
Neurocosmetics admin Mon, 05/27/2024 - 16:30 Vinay Kumar Singh. Head-Formulation Kumar Organic Products Research Centre Pvt. Ltd., Bengaluru Email : formulation_krc@kopresearchcentre.
BioPharm
MAY 27, 2024
In this podcast, we will explore the advantages of partnering with a Contract Development and Manufacturing Organization (CDMO) to navigate the journey from molecule conception to clinical trials, including the expertise, experience, and preparedness that a CDMO brings to the table. The audience will gain valuable insights into crucial questions such as the optimal stage in the development process to engage with a CDMO, the necessary preparations for a successful collaboration, and whether a fin
PharmExec
MAY 27, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Technology
MAY 27, 2024
South Korea has approved Eisai and Biogen’s LEQEMBI for adults with mild cognitive impairment due to mild Alzheimer's disease (AD).
PharmExec
MAY 27, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Technology
MAY 27, 2024
Dr. Reddy's Laboratories' Russian subsidiary and Novartis Pharma signed a deal for the distribution of anti-diabetes products.
BioPharm
MAY 27, 2024
Partnering with a CDMO can help streamline drug development, and certain preparations can help ensure a successful collaboration. Scott Alderucci, Curia’s Director of Process Development, explores the advantages of partnering with a CDMO to navigate the journey from molecule conception to clinical trials, including the expertise, experience, and preparedness that a CDMO brings to the table.
Pharmaceutical Technology
MAY 27, 2024
Dimerix has entered into an agreement with Taiba to commercialise DMX-200 for treating FSGS kidney disease in the Middle East.
Therapeutics Education Collaboration
MAY 27, 2024
In episode 575, James and Mike invite Jamie Falk back to the podcast to help us sift through all the evidence for using oral contraceptives and spironolactone to treat acne. We find that they actually do work. We go over all the numbers for the benefits and harms. Have a listen. Show notes Tools for Practice Facing the Evidence in Acne, Part I: Oral contraceptives and spironolactone in females In episode 575, James and Mike invite Jamie Falk back to the podcast to help us sift through all the ev
Pharmaceutical Technology
MAY 27, 2024
Eli Lilly has annaounced a $5.3bn investment at its site in Lebanon, Indiana, US, to enhance API manufacturing capacity.
Pharmaceutical Commerce
MAY 27, 2024
The transaction serves as way to expand customers’ access to products and capabilities.
BioPharm
MAY 27, 2024
Webinar Date/Time: Thu, Jun 20, 2024 10:00 AM EDT
European Pharmaceutical Review
MAY 27, 2024
A new $5.3 billion investment for Eli Lilly and Company ’s manufacturing site in Lebanon, Indiana, US, increases the firm’s total investment there from $3.7 billion to $9 billion. This expansion will expand manufacturing capacity of active pharmaceutical ingredients (APIs) for Zepbound ® (tirzepatide) injection and Mounjaro ® (tirzepatide) injection.
The Checkup by Singlecare
MAY 27, 2024
According to the Centers for Disease Control and Prevention (CDC), 65% of women of childbearing age (15-49) use some form of birth control to prevent pregnancy. One popular choice, the birth control pill, is 99% effective when taken at the same time every day, but common side effects include mood changes, weight gain, abnormal bleeding, breast tenderness, and increased risk of blood clots.
Expert insights. Personalized for you.
139 
Let's personalize your content